223 results on '"Nielsen, Elisabet I."'
Search Results
2. The complexities of communication at hospital discharge of older patients: a qualitative study of healthcare professionals’ views
3. Therapeutic drug monitoring of vancomycin and meropenem: Illustration of the impact of inaccurate information in dose administration time
4. Predicting cytokine kinetics during sepsis; a modelling framework from a porcine sepsis model with live Escherichia coli
5. Recommended dosages of analgesic and sedative drugs in intensive care result in a low incidence of potentially toxic blood concentrations
6. Changes in critical inhaler technique errors in inhaled COPD treatment – A one-year follow-up study in Sweden
7. Population pharmacokinetics of cefotaxime in intensive care patients
8. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors
9. Estimated glomerular filtration rate as a tool for early identification of patients with insufficient exposure to beta-lactam antibiotics in intensive care units
10. Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infections
11. Therapeutic drug monitoring of vancomycin and meropenem: illustration of the impact of inaccurate information in dose administration time
12. Model‐based assessment of neutrophil‐mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies
13. Critical inhaler technique errors in Swedish patients with COPD: a cross-sectional study analysing video-recorded demonstrations
14. Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time–kill experiments: agreement with in silico predictions.
15. Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
16. A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP
17. Risk factors for and preventability of drug‐related hospital revisits in older patients: A post‐hoc analysis of a randomized clinical trial
18. Risk factors for and preventability of drug‐related hospital revisits in older patients: A post‐hoc analysis of a randomized clinical trial
19. Research priorities towards precision antibiotic therapy to improve patient care
20. Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring
21. A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection
22. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling
23. Population Pharmacokinetic Analysis of Vaginally and Intravenously Administered Oxytocin in Postmenopausal Women
24. Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data
25. Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs
26. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections
27. Levodopa‐entacapone‐carbidopa intestinal gel in Parkinsonʼs disease: A randomized crossover study
28. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden
29. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors
30. Continuous infusion of piperacillin‐tazobactam significantly improves target attainment in children with cancer and fever
31. Population pharmacokinetics of cefotaxime in intensive care patients
32. A Neonatal Amikacin Covariate Model Can Be Used to Predict Ontogeny of Other Drugs Eliminated Through Glomerular Filtration in Neonates
33. Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model
34. Continuous infusion of piperacillin‐tazobactam significantly improves target attainment in children with cancer and fever.
35. Quantitation of seven sedative and analgesic drugs in whole blood from intensive care patients using liquid chromatography mass spectrometry
36. Effects of Hospital-Based Comprehensive Medication Reviews Including Postdischarge Follow-up on Older Patients’ Use of Health Care
37. Developmental Pharmacokinetics of Gentamicin in Preterm and Term Neonates: Population Modelling of a Prospective Study
38. Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime
39. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae : interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data
40. Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments
41. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data
42. Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments
43. Extension of Pharmacokinetic/Pharmacodynamic Time-Kill Studies To Include Lipopolysaccharide/Endotoxin Release from Escherichia coli Exposed to Cefuroxime
44. Intervention fidelity and process outcomes of medication reviews including post‐discharge follow‐up in older hospitalized patients: Process evaluation of the MedBridge trial
45. A novel mechanism-based pharmacokinetic–pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteria
46. Bayesian Forecasting Utilizing Bleeding Information to Support Dose Individualization of Factor VIII
47. Erratum to: Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen
48. A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6
49. A Pharmacokinetic-Pharmacodynamic model built on in vitro data predicts the antibacterial effect of polymyxin B against Klebsiella pneumoniae in vivo
50. From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.